Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy
- 1 July 1997
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 38 (5), 941-947
- https://doi.org/10.1016/s0360-3016(97)00082-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- 1 Results of 3d conformal radiotherapy in the treatment of 707 patients with localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Critical Evaluation of Salvage Surgery for Radio-Recurrent/Resistant Prostate CancerJournal of Urology, 1995
- The prognostic importance of gleason grade in prostatic adenocarcinoma: A long-term follow-up study of 648 patients treated with radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implicationsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesUrology, 1994
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994
- Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancerCancer, 1993
- The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancerCancer, 1993
- Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Effect of external beam radiation therapyon serum prostate-specific antigenUrology, 1990